Rate My Professor Vicky Cameron

Cameron's research centers on cardiovascular genomics and epigenetics, exploring genetic, epigenetic, and environmental influences on heart disease susceptibility, development, and progression. She led the Omics Laboratory, investigating gene expression and pathology in heart disease models, genetic variations associated with clinical outcomes in New Zealand patients, non-coding RNAs such as ANRIL at chromosome 9p21 contributing to coronary heart disease, and circulating microRNAs as prognostic biomarkers post-acute coronary syndrome. Principal investigator on major cohort studies including the Christchurch Family Heart Study, Christchurch Healthy Volunteers Study, Hauora Manawa Māori Community Heart Study, and Pasifika Heart Study, encompassing over 5,000 participants to assess cardiovascular risk in diverse populations. Her contributions include pivotal studies on natriuretic peptides in cardiac fibrosis and the chromosome 9p21 genomic risk locus for coronary heart disease and atherosclerosis. With over 200 publications and more than 5,900 citations, Cameron has significantly impacted the field. She has held influential positions such as Chair of the Health Research Council Biomedical Research Committee (2019-2022), Marsden Fund Council member (2014-2017), and International Ambassador for the American Heart Association Council on Genomic and Precision Medicine. Major awards include Officer of the New Zealand Order of Merit (ONZM, 2017) for services to health, Gold Medal for Research (University of Otago Christchurch, 2019), Leadership Award (2018), and American Heart Association International Fellowship (2011).